Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium Kabi vs Esmeron in general anesthesia induction and maintenance
CTR20130245Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rocuronium in None, sponsored by Fresenius Kabi. Started Dec 2018; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on CTR20130245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130245.